A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...
Spanish researchers achieved complete pancreatic tumor elimination in mice using a triple-drug strategy targeting KRAS and ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several ...
Belite Bio (BLTE) stock outlook: tinlarebant clinical data, 2026 filings, key FDA/EU risks, and $165/share valuation. See if ...
Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
A new study from researchers in Spain discovered that triple therapy could entirely eliminate pancreatic cancer in mice.
For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.
Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results